These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 991628

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Iatrogenic morbidity in patients taking depot fluphenazine.
    Jose C, Mallya A, Mehta D, Evenson R, Holland R.
    Am J Psychiatry; 1979 Jul; 136(7):976-7. PubMed ID: 453363
    [No Abstract] [Full Text] [Related]

  • 6. The use of fluphenazines in a continuing-care program.
    Owens D.
    Hosp Community Psychiatry; 1978 Feb; 29(2):115-8. PubMed ID: 620998
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The risk/benefit ratio of depot neuroleptics: a Scandinavian perspective.
    Dencker SJ.
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):22-7. PubMed ID: 6143744
    [Abstract] [Full Text] [Related]

  • 9. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
    Roose K.
    Acta Psychiatr Belg; 1982 May; 82(2):216-23. PubMed ID: 7180558
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Practical considerations in the use of depot neuroleptics for the treatment of schizophrenia.
    Johnson DA.
    Br J Hosp Med; 1977 Jun; 17(6):546-58. PubMed ID: 18242
    [No Abstract] [Full Text] [Related]

  • 12. Side effects of depot fluphenazines.
    Ayd FJ.
    Compr Psychiatry; 1974 Jun; 15(4):277-84. PubMed ID: 4607070
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [The position of the depot-neuroleptics in the therapy of chronic psychoses. Experience with fluphenazine-decanoate].
    Auch W.
    Med Welt; 1970 Oct 10; 21(41):1785-8. PubMed ID: 5471981
    [No Abstract] [Full Text] [Related]

  • 15. Discontinuation of oral and depot fluphenazine in schizophrenic patients after one year of continuous medication: a controlled study.
    Levine J, Schooler NR, Severe J, Escobar J, Gelenberg A, Mandel M, Sovner R, Steinbook R.
    Adv Biochem Psychopharmacol; 1980 Oct 10; 24():483-93. PubMed ID: 6996445
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Depot phenothiazine treatment in acute psychosis: a sequential comparative clinical study.
    Chien CP, Cole JO.
    Am J Psychiatry; 1973 Jan 10; 130(1):13-8. PubMed ID: 4566388
    [No Abstract] [Full Text] [Related]

  • 20. Neuroleptic malignant syndrome due to depot fluphenazine.
    Grunhaus L, Sancovici S, Rimon R.
    J Clin Psychiatry; 1979 Feb 10; 40(2):99-100. PubMed ID: 762037
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.